NCT04104503View on ClinicalTrials.gov

A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

April 9, 2020

Study Completion Date

April 9, 2020

Conditions
Healthy
Interventions
DRUG

Lu AF11167

Lu AF11167 - 2 mg modified release tablets (reference formulation), up to 5 prototype MR tablet formulations (test formulations)

DRUG

[14C]-Lu AF11167

single iv microdose administered as a 15 minutes infusion

DRUG

Lu AF11167 MR tablet prototype formulation selected from part A or 1 mg modified release tablet (reference formulation)

Single oral dose

Trial Locations (1)

Unknown

Quotient, Nottingham

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04104503 - A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects | Biotech Hunter | Biotech Hunter